RxDoctor Payments Data

David Mobley, MD

Vascular & Interventional Radiology · New York, NYNPI 1457632580

Payments from drug & device makers

What this record shows

This record is dominated by other: $75,000 of the $79,627 with a category attached, or 94.2%. Angiodynamics, Inc. accounts for 94.3% of it on its own, with 17 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$79,627in general payments, 2019–2025

Across 83 payments — averaging $959.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$75K
  • Penumbra, Inc.$2K
  • Vasorum USA Inc.$557
  • Tepha Inc$557
  • Sirtex Medical Inc$421
  • Bard Peripheral Vascular, Inc.$323
  • plus $896 from 12 others
$13,300in research payments, 2019–2025

Across 2 payments — averaging $6650.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merit Medical Systems Inc$13K

What the payments were for

  • Travel & lodging$480%
  • Food & beverage$4,5286%
  • Education$500%
  • Other$75,00094%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$79,627 in reported general payments places this provider in the 90th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$271,194
Medicare patients
106
Services billed
3,022

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate90$433
Ciprofloxacin Hcl48$317
Ibuprofen47$192
Cilostazol13$160
Atorvastatin Calcium36$160

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →